NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-142-2011-0-DE-07 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subjects From Diabetes or Obesity DE EP 12773975.3 Issued
NIDCR E-142-2011-0-FR-08 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subjects From Diabetes or Obesity FR EP 12773975.3 Issued
NIDCR E-142-2011-0-GB-09 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subjects From Diabetes or Obesity GB EP 12773975.3 Issued
NCI E-281-2012-2-PCT-01 INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE PCT PCT COMB PCT/US2013/070813 Expired
NCI E-281-2012-2-EP-04 INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE EP National Stage 13857490.0 Abandoned
NCI E-281-2012-2-AU-02 INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE AU National Stage 2013348112 Abandoned
NCI E-281-2012-2-CA-03 INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE CA National Stage 2891425 Abandoned
NCI E-096-2011-0-US-03 Method of Selecting Cancer Patients for Anti-Angiogenesis Therapy In Combination with Chemotherapy US National Stage 14/002,455 Abandoned
NICHD E-071-2013-0-US-01 A Method To Detect Non-Gaussian Diffusion With Symmetrized Double PFG NMR US 61/905,680 Abandoned
NICHD E-016-2013-2-EP-03 Assay to Measure Midkine or Pleiotrophin Level for Diagnosing a Growth EP National Stage 13798508.1 Issued
NICHD E-016-2013-2-PCT-01 Assay to Measure Midkine or Pleiotrophin Level for Diagnosing a Growth PCT PCT COMB PCT/US2013/070305 Expired
NIAMS E-762-2013-0-US-01 ENGINEERING NEURAL STEM CELLS USING HOMOLOGOUD RECOMBINATION US 61/904,999 Abandoned
NCATS E-751-2013-0-US-01 Method of Blocking Transmission of Malarial Parasite US 61/904,884 Abandoned
NIAMS E-763-2013-0-US-01 Compositions for Modification of Genomic DNA and Exogenous Gene Expression and Related Applications US 61/905,002 Abandoned
NCATS E-148-2012-0-CA-04 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS CA National Stage 2891340 Issued
NCATS E-148-2012-0-EP-06 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS EP National Stage 13814276.5 Issued
NCATS E-148-2012-0-CN-05 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS CN National Stage 201380067222.9 Issued
NCATS E-148-2012-0-PCT-02 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS PCT PCT PCT/US2013/070156 Expired
NCATS E-148-2012-0-CN-11 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS CN DIV 201710324887.3 Abandoned
NIAMS E-073-2011-1-MX-08 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology MX National Stage MX/a/2013/013329 Abandoned
NCATS E-148-2012-0-AU-03 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS AU National Stage 2013344651 Abandoned
NHLBI E-516-2013-0-US-01 DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AND MYOCARDIAL INFARCTION RISK US 61/904,408 Abandoned
NHLBI E-515-2013-0-US-01 DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AND HEART FAILURE RISKd US 61/904,410 Abandoned
NIA E-103-2011-2-US-02 USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS US National Stage 14/117,589 9932560 Issued PDF
NCI E-201-2012-0-EP-07 Methods of Treating Patients Infected with HIV and HTLV EP National Stage 13802766.9 Abandoned
NCI E-201-2012-0-PCT-02 Methods of Treating Patients Infected with HIV and HTLV PCT PCT PCT/US2013/069796 Expired
NIAID E-148-1999-0-JP-21 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-3 and IL-13 RECEPTOR CHAINS JP DIV 2013-232738 Abandoned
NCI E-201-2012-0-AU-04 Methods of Treating Patients Infected with HIV and HTLV AU National Stage 2013344970 Abandoned
NCI E-201-2012-0-CA-05 Methods of Treating Patients Infected with HIV and HTLV CA National Stage 2891294 Abandoned
NIAAA E-282-2012-0-CA-04 CANNABINOID RECEPTOR MEDIATING COMPOUNDS CA National Stage 2889697 Issued
NIAAA E-282-2012-0-CH-12 CANNABINOID RECEPTOR MEDIATING COMPOUNDS CH EP 13802153.0 Issued
NIAAA E-282-2012-0-DE-13 CANNABINOID RECEPTOR MEDIATING COMPOUNDS DE EP 13802153.0 Issued
NIAAA E-282-2012-0-IE-16 CANNABINOID RECEPTOR MEDIATING COMPOUNDS IE EP 13802153.0 Issued
NIAAA E-282-2012-0-FR-14 CANNABINOID RECEPTOR MEDIATING COMPOUNDS FR EP 13802153.0 Issued
NIAAA E-282-2012-0-EP-05 CANNABINOID RECEPTOR MEDIATING COMPOUNDS EP National Stage 13802153.0 Issued
NIAAA E-282-2012-0-GB-15 CANNABINOID RECEPTOR MEDIATING COMPOUNDS GB EP 13802153.0 Issued
NIAAA E-282-2012-0-IN-06 CANNABINOID RECEPTOR MEDIATING COMPOUNDS IN National Stage 3733/DELNP/2015 Issued
NIAAA E-282-2012-0-CN-08 CANNABINOID RECEPTOR MEDIATING COMPOUNDS CN National Stage 201380069389.9 Issued
NIAAA E-282-2012-0-JP-07 CANNABINOID RECEPTOR MEDIATING COMPOUNDS JP National Stage 2015-542015 Issued
NICHD E-057-2008-0-CA-07 Use Of Ulipristal For Treating Uterine Fibroids CA National Stage 2713254 Issued
NIAAA E-282-2012-0-PCT-02 CANNABINOID RECEPTOR MEDIATING COMPOUNDS PCT PCT PCT/US2013/069686 Expired
CC E-173-2011-0-US-04 SYSTEM AND METHOD FOR PROBABILISTIC ABLATION PLANNING US National Stage 13/885,714 10423757 Issued PDF
NIAID E-242-2011-0-US-05 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing US National Stage 14/116,710 10273291 Issued PDF
NCI E-316-2008-0-US-03 Methods And Systems Using Therapeutic, Diagnostic, or Prophylactic Magnetic Agents US CON 14/075,408 9108035 Issued PDF
NCI E-081-2011-0-US-03 Tropolone Compounds for Treating or Preventing Retroviral Infection US National Stage 14/116,423 8993768 Issued PDF
NICHD E-157-2011-0-DK-08 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same DK EP 12716889.6 Issued
NICHD E-157-2011-0-DE-07 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same DE EP 12716889.6 Issued
NICHD E-157-2011-0-FI-09 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same FI EP 12716889.6 Issued
NICHD E-157-2011-0-SE-11 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same SE EP 12716889.6 Issued
NICHD E-157-2011-0-GB-10 Small Molecule Therapeutic Compounds Targeting Thioesterase Deficiency Disorders and Methods of Using the Same GB EP 12716889.6 Issued